+1 347 708 0418
Mild-to-Moderate Atopic Dermatitis Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Mild-to-Moderate Atopic Dermatitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Radiation Treatment
Drug Treatment
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Company
Novartis
Pfizer
Sanofi
Anacor Pharmaceuticals
Astellas Pharma
Meda Pharmaceuticals
Regeneron Pharmaceuticals
Bausch Health
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Radiation Treatment
1.2.3 Drug Treatment
1.3 Market by Application
1.3.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Perspective (2017-2028)
2.2 Mild-to-Moderate Atopic Dermatitis Treatment Growth Trends by Region
2.2.1 Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Mild-to-Moderate Atopic Dermatitis Treatment Historic Market Size by Region (2017-2022)
2.2.3 Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Region (2023-2028)
2.3 Mild-to-Moderate Atopic Dermatitis Treatment Market Dynamics
2.3.1 Mild-to-Moderate Atopic Dermatitis Treatment Industry Trends
2.3.2 Mild-to-Moderate Atopic Dermatitis Treatment Market Drivers
2.3.3 Mild-to-Moderate Atopic Dermatitis Treatment Market Challenges
2.3.4 Mild-to-Moderate Atopic Dermatitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mild-to-Moderate Atopic Dermatitis Treatment Players by Revenue
3.1.1 Global Top Mild-to-Moderate Atopic Dermatitis Treatment Players by Revenue (2017-2022)
3.1.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mild-to-Moderate Atopic Dermatitis Treatment Revenue
3.4 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Concentration Ratio
3.4.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mild-to-Moderate Atopic Dermatitis Treatment Revenue in 2021
3.5 Mild-to-Moderate Atopic Dermatitis Treatment Key Players Head office and Area Served
3.6 Key Players Mild-to-Moderate Atopic Dermatitis Treatment Product Solution and Service
3.7 Date of Enter into Mild-to-Moderate Atopic Dermatitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mild-to-Moderate Atopic Dermatitis Treatment Breakdown Data by Type
4.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Historic Market Size by Type (2017-2022)
4.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Type (2023-2028)
5 Mild-to-Moderate Atopic Dermatitis Treatment Breakdown Data by Application
5.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Historic Market Size by Application (2017-2022)
5.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2017-2028)
6.2 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
6.2.1 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2017-2022)
6.2.2 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2023-2028)
6.2.3 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2017-2028)
6.3 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application
6.3.1 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2017-2022)
6.3.2 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2023-2028)
6.3.3 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2017-2028)
6.4 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country
6.4.1 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2017-2022)
6.4.2 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2017-2028)
7.2 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
7.2.1 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2017-2022)
7.2.2 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2023-2028)
7.2.3 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2017-2028)
7.3 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application
7.3.1 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2017-2022)
7.3.2 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2023-2028)
7.3.3 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2017-2028)
7.4 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country
7.4.1 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2017-2022)
7.4.2 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2017-2028)
8.2 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
8.2.1 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application
8.3.1 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Region
8.4.1 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2017-2028)
9.2 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
9.2.1 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2017-2028)
9.3 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application
9.3.1 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2017-2028)
9.4 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country
9.4.1 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2017-2028)
10.2 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type
10.2.1 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application
10.3.1 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country
10.4.1 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.1.4 Novartis Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
11.1.5 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.2.4 Pfizer Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.3.4 Sanofi Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
11.3.5 Sanofi Recent Developments
11.4 Anacor Pharmaceuticals
11.4.1 Anacor Pharmaceuticals Company Details
11.4.2 Anacor Pharmaceuticals Business Overview
11.4.3 Anacor Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.4.4 Anacor Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
11.4.5 Anacor Pharmaceuticals Recent Developments
11.5 Astellas Pharma
11.5.1 Astellas Pharma Company Details
11.5.2 Astellas Pharma Business Overview
11.5.3 Astellas Pharma Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.5.4 Astellas Pharma Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
11.5.5 Astellas Pharma Recent Developments
11.6 Meda Pharmaceuticals
11.6.1 Meda Pharmaceuticals Company Details
11.6.2 Meda Pharmaceuticals Business Overview
11.6.3 Meda Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.6.4 Meda Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
11.6.5 Meda Pharmaceuticals Recent Developments
11.7 Regeneron Pharmaceuticals
11.7.1 Regeneron Pharmaceuticals Company Details
11.7.2 Regeneron Pharmaceuticals Business Overview
11.7.3 Regeneron Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.7.4 Regeneron Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
11.7.5 Regeneron Pharmaceuticals Recent Developments
11.8 Bausch Health
11.8.1 Bausch Health Company Details
11.8.2 Bausch Health Business Overview
11.8.3 Bausch Health Mild-to-Moderate Atopic Dermatitis Treatment Introduction
11.8.4 Bausch Health Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
11.8.5 Bausch Health Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Radiation Treatment
Table 3. Key Players of Drug Treatment
Table 4. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Region (2017-2022)
Table 8. Global Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Region (2023-2028)
Table 10. Mild-to-Moderate Atopic Dermatitis Treatment Market Trends
Table 11. Mild-to-Moderate Atopic Dermatitis Treatment Market Drivers
Table 12. Mild-to-Moderate Atopic Dermatitis Treatment Market Challenges
Table 13. Mild-to-Moderate Atopic Dermatitis Treatment Market Restraints
Table 14. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Share by Players (2017-2022)
Table 16. Global Top Mild-to-Moderate Atopic Dermatitis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mild-to-Moderate Atopic Dermatitis Treatment as of 2021)
Table 17. Ranking of Global Top Mild-to-Moderate Atopic Dermatitis Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Mild-to-Moderate Atopic Dermatitis Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Mild-to-Moderate Atopic Dermatitis Treatment Product Solution and Service
Table 21. Date of Enter into Mild-to-Moderate Atopic Dermatitis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Share by Application (2017-2022)
Table 29. Global Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Share by Application (2023-2028)
Table 31. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Mild-to-Moderate Atopic Dermatitis Treatment Product
Table 64. Novartis Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022) & (US$ Million)
Table 65. Novartis Recent Developments
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Mild-to-Moderate Atopic Dermatitis Treatment Product
Table 69. Pfizer Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022) & (US$ Million)
Table 70. Pfizer Recent Developments
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Mild-to-Moderate Atopic Dermatitis Treatment Product
Table 74. Sanofi Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022) & (US$ Million)
Table 75. Sanofi Recent Developments
Table 76. Anacor Pharmaceuticals Company Details
Table 77. Anacor Pharmaceuticals Business Overview
Table 78. Anacor Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Product
Table 79. Anacor Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022) & (US$ Million)
Table 80. Anacor Pharmaceuticals Recent Developments
Table 81. Astellas Pharma Company Details
Table 82. Astellas Pharma Business Overview
Table 83. Astellas Pharma Mild-to-Moderate Atopic Dermatitis Treatment Product
Table 84. Astellas Pharma Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022) & (US$ Million)
Table 85. Astellas Pharma Recent Developments
Table 86. Meda Pharmaceuticals Company Details
Table 87. Meda Pharmaceuticals Business Overview
Table 88. Meda Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Product
Table 89. Meda Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022) & (US$ Million)
Table 90. Meda Pharmaceuticals Recent Developments
Table 91. Regeneron Pharmaceuticals Company Details
Table 92. Regeneron Pharmaceuticals Business Overview
Table 93. Regeneron Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Product
Table 94. Regeneron Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022) & (US$ Million)
Table 95. Regeneron Pharmaceuticals Recent Developments
Table 96. Bausch Health Company Details
Table 97. Bausch Health Business Overview
Table 98. Bausch Health Mild-to-Moderate Atopic Dermatitis Treatment Product
Table 99. Bausch Health Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022) & (US$ Million)
Table 100. Bausch Health Recent Developments
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type: 2021 VS 2028
Figure 2. Radiation Treatment Features
Figure 3. Drug Treatment Features
Figure 4. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application: 2021 VS 2028
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Mild-to-Moderate Atopic Dermatitis Treatment Report Years Considered
Figure 9. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Region: 2021 VS 2028
Figure 12. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Players in 2021
Figure 13. Global Top Mild-to-Moderate Atopic Dermatitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mild-to-Moderate Atopic Dermatitis Treatment as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Mild-to-Moderate Atopic Dermatitis Treatment Revenue in 2021
Figure 15. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size Market Share by Type (2017-2028)
Figure 17. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size Market Share by Application (2017-2028)
Figure 18. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size Share by Country (2017-2028)
Figure 19. United States Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size Market Share by Type (2017-2028)
Figure 23. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size Market Share by Application (2017-2028)
Figure 24. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size Share by Country (2017-2028)
Figure 25. Germany Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Mild-to-Moderate Atopic Dermatitis Treatment Market Size Share by Region (2017-2028)
Figure 35. China Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Mild-to-Moderate Atopic Dermatitis Treatment Market Size Share by Country (2017-2028)
Figure 45. Mexico Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Mild-to-Moderate Atopic Dermatitis Treatment Market Size Share by Country (2017-2028)
Figure 51. Turkey Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Novartis Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
Figure 55. Pfizer Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
Figure 56. Sanofi Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
Figure 57. Anacor Pharmaceuticals Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
Figure 58. Astellas Pharma Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
Figure 59. Meda Pharmaceuticals Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
Figure 60. Regeneron Pharmaceuticals Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
Figure 61. Bausch Health Revenue Growth Rate in Mild-to-Moderate Atopic Dermatitis Treatment Business (2017-2022)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Buy
